In Vivo is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zogenix Inc.

www.zogenix.com

Latest From Zogenix Inc.

Resubmission After Withdrawal: US FDA’s Mavenclad Approval Acknowledges Long Regulatory History

EMD Serono’s multiple sclerosis drug joins small cadre of products that survived a refuse to file letter and NDA withdrawal; chart details recent RTFs and application withdrawals.

Drug Approval Standards Drug Review

Keeping Track: NME Approvals For Evenity And Balversa; Non-NME Approvals For Dovato And Keytruda; But An RTF For Fintepla

The latest drug development news and highlights from our US FDA Performance Tracker. 
Drug Review Regulation

US FDA Filing Mistake For Fintepla Dents Zogenix

Zogenix seems only to have itself to blame for an unexpected refusal to file letter from the US agency for its novel treatment for Dravet syndrome that sent its shares tumbling by 31% on NASDAQ in after-hours trading.

Drug Review Policy & Regulation

Pharma Legislation: From Pricing To Patents

Our table details more than 30 pharma-related bills introduced in the US Congress this year that target drug pricing, generics, patents, market exclusivity, and FDA approval of opioids.
Legislation Pricing Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • SJ2 Therapeutics Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Zogenix Inc.
  • Senior Management
  • Stephen J Farr, PhD, Pres. & CEO
    Michael P Smith, EVP, CFO, Treasurer & Secretary
    Bradley S Galer, MD, EVP, CMO
    Gail M Farfel, PhD, EVP, Chief Dev. Officer
    Ashish Sagrolikar, EVP, Chief Commercial Officer
  • Contact Info
  • Zogenix Inc.
    Phone: (858) 259-1165
    5858 Horton St.
    Ste. 455
    Emeryville, CA 94608
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register